Nutraveris

Category 'News'

Thursday, April 27, 2017

Pomegranate seed oil may reduce menopausal symptoms.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

Pomegranate seed oil is traditionally used for the treatment of various disorders, including menopausal disorders. The purpose of this trial was to confirm the beneficial effects of pomegranate seed oil on in women with menopausal discomfort.

 Pomegranate

 78 women with menopausal symptoms for an average time of 46 months received 1000 mg of pomegranate seed oil for 8 weeks. The β-sitosterol content of the supplement was 6.3 mg/1000 mg. A significant decrease in menopausal symptoms has been measured, notably regarding hot flashes (score reduced from 2.32 ± 1.04 to 1.41 ± 1.07, p < 0.001).

Similarly, urogenital tract symptoms (i.e. vaginal dryness) has been also reduced (2.32 ± 1.04 to 0.85 ± 1.19, p < 0.001).

Results showed also a good tolerability of the product, and no change in 17β estradiol has been reported.

 Thus, pomegranate seed oil may be useful for the management of menopausal symptoms. However, larger well-designed studies are required to confirm the interest of pomegranate seed oil.

 

Huber R, Gminski R, Tang T, Weinert T, Schulz S, Linke-Cordes M, Martin I, Fischer H. Pomegranate (Punica granatum) Seed Oil for Treating Menopausal Symptoms: An Individually Controlled Cohort Study. Altern Ther Health Med. 2017 Mar;23(2):28-34.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Monday, April 24, 2017

Lactobacillus rhamnosus supplementation does not help to improve constipation in children.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

The objective of this randomized, double-blind, placebo-controlled trial was to assess the effectiveness of Lactobacillus casei rhamnosus Lcr35 in the management of functional constipation in children. A total of 94 children aged <5 years with functional constipation according to the Rome III criteria, were assigned to receive L. rhamnosus (8×108 CFU, n = 46) or placebo (n = 48), twice daily, for 4 weeks.

Childrens'constipation

There was no significant difference in treatment success between the placebo and the L. rhamnosus group (p = 0.4). There was a significant increase in the frequency of defecation from baseline to week 4 in both the placebo group (p < 0.001) and in the L. rhamnosus group (p < 0.001), but the defecation frequency in the placebo group was significantly greater than that in the L. rhamnosus group at weeks 1, 2, 3, and 4. L rhamnosus as a sole treatment was not more effective than placebo in the management of functional constipation in children. This study adds to current recommendations that do not support the use of probiotics in the treatment of childhood constipation.

 

 

Wojtyniak K, Horvath A, Dziechciarz P, Szajewska H. Lactobacillus casei rhamnosus Lcr35 in the Management of Functional Constipation in Children: A Randomized Trial. J Pediatr. 2017 Mar 8.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Wednesday, April 19, 2017

Let’s meet at Vitafoods, Geneva, on May 9-11th

Nutraveris, the Regulatory and Scientific Expert in Nutrition and Health to help you conceive and launch your products in Europe, will be at VITAFOODS on May 9-11th 2017,  booth E42.

On this occasion, please come and discover our brand new feature of our DATA Solution NUTRAVERIS ONLINE: the complete  Regulatory, Scientific and Marketing  collaborative tool for your team which enables you to:

  • Create the best products in their categories
  • Solve all regulatory issues
  • Protect your investments
  • Be the most responsive
Nutraveris'Vitafoods'stand E42
Our scientific and regulatory experts will be glad to welcome you, present our new support solution and discuss your projects in Europe.
Just fill in the below form to book an appointment with them, during this three-days event:

Book here your meeting

 


 

 

 

Tuesday, April 18, 2017

Probiotics for digestive health in adults: two meta-analyzes.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

Probiotics are well-known for their beneficial effects on gut microflora. Two meta-analyzes have examined the scientific evidences substantiating the effect of probiotics on inflammatory bowel diseases or gastrointestinal discomfort.

 Probiotics

Probiotics may have no effect on Crohn’s disease (9 trials, p = 0.07), but have a significant beneficial effects in children with inflammatory bowel diseases (3 trials, p = 0.01). Moreover, studies have shown that probiotics in patients with ulcerative colitis have significant effects (18 trials, p =0.007).

In the general population, the consumption of fermented milk that includes Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria is associated with a significant improvement in overall gastrointestinal discomfort compared to control (OD=1.48, 95% CI: 1.07-2.05). Fermented milk was also superior to control in reducing digestive symptoms.

These meta-analyzes confirm consequently the interest of probiotics for the management of digestive health, both in the general population and in patients with inflammatory bowel diseases.

Eales J, Gibson P, Whorwell P, Kellow J, Yellowlees A, Perry RH, Edwards M, King S, Wood H, Glanville J. Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol. 2017 Jan;10(1):74-88.

Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics Are a Good Choice in Remission of Inflammatory Bowel Diseases: A Meta Analysis and Systematic Review. J Cell Physiol. 2017 Mar 15.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, April 13, 2017

Blueberry improves cognition among older adults.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

This randomized, double-blind, placebo-controlled study aim was to assess the effect of dietary blueberry to improve mobility and cognition among older adults. 13 men and 24 women, between the ages of 60 and 75 years, were recruited to consume either freeze-dried blueberry (24 g/day, equivalent to 1 cup of fresh blueberries) or a blueberry placebo for 90 days.

 

Blueberry

 

Significant supplement group by study visit interactions were observed on tests of executive function. Participants in the blueberry group showed significantly fewer repetition errors in the California Verbal Learning test (p = 0.031, ηp(2) = 0.126) and reduced switch cost on a task-switching test (p = 0.033, ηp(2) = 0.09) across study visits, relative to controls.

However, no improvement in gait or balance was observed. Authors concluded the addition of easily achievable quantities of blueberry to the diets of older adults can improve some aspects of cognition.

 

Miller MG, Hamilton DA, Joseph JA, Shukitt-Hale B. Dietary blueberry improves cognition among older adults in a randomized, double-blind, placebo-controlled trial. Eur J Nutr. 2017 Mar 10.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87